Skip to main content
CBLL
NASDAQ Life Sciences

Ceribell Launches First FDA-Cleared Delirium Monitor With $2,171 CMS Add-On Payment

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$26.58
Mkt Cap
$1.02B
52W Low
$10.85
52W High
$28.19
52W Position info
145% above low
Off High info
5.7% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

CBLL has more than doubled off its 52-week low of $10.85.

Summary

Ceribell began selling its delirium monitoring module on the existing Ceribell EEG headband, making it the first and only FDA-cleared device to aid delirium screening and monitoring. The clearance came in December 2025; this is the revenue-generating step, following a multi-hospital pilot. CMS granted a New Technology Add-on Payment of up to $2,171 per eligible Medicare case effective October 1, 2026, which removes a real adoption hurdle for hospitals weighing the cost. The pitch is large: delirium hits roughly 30% of ICU patients and up to 80% of those on ventilators, and the same hardware already sits in accounts using seizure detection. This lands after a strong Q2 ($28.1M revenue, up 33% year-over-year, guidance raised to $114M-$117M), so the launch is the next leg of that growth story rather than a rescue.

At the time of this announcement, CBLL was trading at $26.58 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1B. The 52-week trading range was $10.85 to $28.19. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

CBLL - Latest Insights

CBLL
Nov 03, 2026, 4:50 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $24.00
Real-time Price: $26.42 info
Change: +$2.42 (+10%) info
Market Cap: $1.009B info
CBLL
Nov 03, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $28.27
Real-time Price: $26.42 info
Change: -$1.85 (-7%) info
Market Cap: $1.009B info
CBLL
Aug 10, 2026, 4:50 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $19.30
Real-time Price: $26.42 info
Change: +$7.12 (+37%) info
Market Cap: $1.009B info
CBLL
Aug 10, 2026, 4:27 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $19.30
Real-time Price: $26.42 info
Change: +$7.12 (+37%) info
Market Cap: $1.009B info
CBLL
Aug 10, 2026, 4:25 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $19.30
Real-time Price: $26.42 info
Change: +$7.12 (+37%) info
Market Cap: $1.009B info